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Background: Migraine is one of the most frequent headache diseases and impairs patients’ quality of life. Up to
now, many randomized studies reported efficacy of prophylactic therapy with medications such as beta-blockers or
anti-epileptic drugs. Non-medical treatment, like aerobic endurance training, is considered to be an encouraging
alternative in migraine prophylaxis. However, there is still a lack of prospective, high-quality randomized trials. We
therefore designed a randomized controlled trial to evaluate the efficacy of aerobic endurance training versus
relaxation training in patients with migraine (ARMIG).
Methods: This is a single-center, open-label, prospective, randomized trial. Sixty participants with migraine are
randomly allocated to either endurance training or a relaxation group. After baseline headache diary documentation
over at least 4 weeks, participants in the exercise group will start moderate aerobic endurance training under a
sport therapist’s supervision at least 3 times a week over a 12-week period. The second group will perform
Jacobson’s progressive muscle relaxation training guided by a trained relaxation therapist, also at least 3 times a
week over a 12-week period. Both study arms will train in groups of up to 10 participants. More frequent individual
training is possible. The follow-up period will be 12 weeks after the training period. The general state of health,
possible state of anxiety or depression, impairments due to the headache disorder, pain-related disabilities, the
headache-specific locus of control, and the motor fitness status are measured with standardized questionnaires.
Discussion: The study design is adequate to generate meaningful results. The trial will be helpful in gaining
important data on exercise training for non-medical migraine prophylaxis.
Trial registration: The trial is registered at ClinicalTrials.gov: NCT01407861.Background
Migraine is the second most frequent primary headache.
With over 10% of people in the German population
affected, migraine is a widespread disease leading to high
healthcare costs and has a major impact on patients’
quality of life. Prophylactic medication, such as beta-
blockers, topiramate, or amitriptyline, is recommended
for patients suffering from three or more headache
attacks a month [1]. However, medical prophylaxis is not
well accepted by many migraine patients due to experi-
enced or anticipated adverse events. Many patients seek
non-medical treatment for migraine [2,3]. Endurance* Correspondence: charly.gaul@gmx.de
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reproduction in any medium, provided the origtraining is recommended [4], in particular as part of
multidisciplinary treatment programs for migraine treat-
ment [5-7]. Until now there has been insufficient
evidence of the efficacy of endurance training due to the
lack of randomized trials. Several studies reported a re-
duction of migraine frequency and intensity with aerobic
endurance training. A major shortcoming of these stud-
ies is small patient numbers and therefore low statistical
power. Aerobic endurance training led to an increased
pain threshold in experimentally-induced pain. Most of
these trials were conducted during the 1980s. Measure-
ment of plasma beta endorphin levels in only a small
number of migraine patients during exercise training
cannot replace randomized trials of efficacy [8].
Recently, a Swedish single-center migraine trial com-
paring exercise training to relaxation training and toLtd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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efficacy of exercise training for prophylactic migraine
treatment [9]. However, randomized trials using different
comparators, especially non-pharmacological treatments,
are not yet available [10].
We therefore initiated a German single-center trial to
study the prophylactic effect of moderate aerobic endurance
training versus relaxation training in patients with migraine.
Relaxation training, such as Jacobson’s progressive
muscle relaxation, has been investigated in several stud-
ies and is effective for migraine prophylaxis [3,11-13].
Design
This is a single-center, open-label, prospective, rando-
mized study on the prophylactic effect of moderate
aerobic endurance training versus relaxation training in
patients with migraine.
The procedures and design of the study were approved
by the Medical Ethics Committee of the University of
Duisburg-Essen in Essen, Germany (Approval number
11–4677) and the study is internationally registered
(ClinicalTrials.gov, Registration number NCT01407861).
The study started in July 2011, and participants are
recruited via local newspapers, study brochures or local
television. Interested participants are informed about the
study protocol. After written informed consent, a sport
therapist will make an appointment to conduct an en-
durance test to determine the optimal training heart rate.
Participants will be examined by a neurologist to confirm
the diagnosis of migraine and to check inclusion and
exclusion criteria (see below). Diagnosis of migraine is
based on the International Classification of Headache
Disorders criteria (ICHD-II) [14].
Inclusion criteria
Inclusion criteria are as follows:
1. The patient’s signature is on the informed consent
document (patients should each be given ample time
to read the consent form, ask any questions they
may have regarding the trial, and have a clear
understanding of the trial and the procedures
involved prior to signing the consent form)
2. Patients have a clinical diagnosis of migraine with or
without aura according to ICHD-II criteria [14] at
least 1 year prior to enrollment
3. Patients have a clinical diagnosis of migraine with or
without aura and, in addition, a clinical diagnosis of
tension-type headache (TTH) according to ICHD-II
[14], if patients are able to differentiate between the
two headache diagnoses and if migraine is more
frequent in patients with TTH
4. Patients report at least three migraine days
per monthExclusion criteria
Exclusion criteria are as follows:
1. Diseases or disabilities that disqualify for performing
either aerobic endurance training or relaxation
training (that is, severe asthma, pacemaker, major
depression, specific physical handicap)
2. Language disabilities that disenable filling out
questionnaires
3. Fewer than three migraine days per month
4. Pregnancy
5. Additional diagnosis of secondary headache
according to the ICHD-II (that is, medication
overuse headache)
6. Prophylactic headache medication started within the
last 12 weeks
7. Regular performance of endurance training and/or
relaxation training at least twice a week
Migraine patients who are stable on prophylactic medi-
cation and meet the inclusion and exclusion criteria may
be enrolled. Participants will be asked to keep a head-
ache diary during the whole study period. Randomization
will be performed at the end of the 4-week baseline
period. Each participant will receive a sealed envelope.
Randomization sequence is composed by an independent
statistician using computer-generated random numbers.
Participants are randomized to either the endurance
training or the relaxation training group (1:1). Overall,
60 participants are planned to be enrolled in the trial.
This is considered as a pilot trial to prove the feasibility
of such a trial design and to achieve data on efficacy of
both therapies.
The treatment (training) period will begin after base-
line headache diary documentation for at least 4 weeks
to obtain baseline number of headache days. Training
will be in groups of up to 10 participants (Figure 1).
Fitness test
Each participant will perform a Physical Working
Capacity Test (PWC) to test the aerobic performance
capacity [15,16]. The test will be done using a computer-
controlled ergometer with specialized software Vitality
System 6.0 (ERGO-FIT, Pirmasens, Germany). The
results, defined as the mathematically-calculated per-
formance at the threshold heart rate, are related to the
participant’s body weight and thus converted to an indi-
vidual value to receive optimal aerobic training heart
rate. All test data will be printed out and filed in the
participant’s case report form (CRF).
Intervention: aerobic endurance training
Participants who are enrolled in the exercise group will
perform endurance training twice a week for 12 weeks
Figure 1 Flow chart of study protocol.
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third training day during the week can be chosen indi-
vidually. More frequent endurance training is possible.
Each training session should be documented in the partici-
pant’s training headache and training diary. Endurance
training consists of indoor cycling with a warm-up period
of 10 min, a 30-min exercise period and a 5-min cool-
down phase. Heart rate will be measured during exercise
training to acquire optimal aerobic training conditions.Active comparison: relaxation training
Participants of the relaxation group (up to 10 people)
will receive expert guidance in relaxation training twice a
week over 12 weeks. A third training day during the
week may also be chosen individually. More frequent
relaxation training is again possible and should be docu-
mented in the participant’s training headache and train-
ing diary. Relaxation training is based upon Jacobson’s
Progressive Muscle Relaxation (or PMR), an approved
technique for reducing stress and anxiety by alternately
tensing and relaxing groups of muscles. Participants will
learn a short (about 10 min) and long (about 30 min)
version of relaxation training. An audio compact disc
containing the relaxation program will be provided to
practice relaxation treatment at home.
Consistent participation in either exercise or relaxation
is important and will be checked regularly. Up to two
absent days in 4 weeks are tolerable.Headache and training diary
The headache diary should be kept every day during the
trial to collect data about pain intensity, duration,
accompanying symptoms, intake of analgesics or triptans,
absent days from work/school, and training days for
endurance training respectively relaxation training.Questionnaires
At baseline, after the 12-week training and 12 weeks
after finishing the training period (follow-up), partici-
pants will be asked to fill out the following internation-
ally-recognized, standardized questionnaires: the SF-12
(short-form 12), a questionnaire about the general state
of health [17]; the HADS-D, a German version of the
Hospital Anxiety and Depression Scale to capture pos-
sible states of anxiety or depression [18]; the HIT-6
(Headache Impact Test) to measure impairments due to
headache disorders [19,20]; the Pain Disability Index
(PDI) to measure pain-related disabilities [21]; the
HSLC-D, a German version of the Headache-Specific
Locus of Control Scale to gather information on the
locus of control in headache patients [22]; the FFB-Mot,
a self-survey on the motor fitness status consisting of 28
self-report items assessing four basic motor abilities,
explicitly cardio-respiratory fitness, strength, flexibility,
and coordination [23].
Primary outcome measure
The primary outcome measure is a reduction of headache
days in the last 4 weeks of the 12-week training compared
to baseline (4 weeks before the start of training).
Secondary outcome measures
Secondary outcome measures are as follows: number of
headache days 12 weeks after finishing the training
(follow-up); consumption of analgesics or triptans;
increase in aerobic capability; impact on burden of
disease; and the psychological impact of training.
Statistical analysis
The aim of this pilot trial is to achieve data on the efficacy
of both therapies. The effect of treatment on primary and
secondary outcomes will be described by mean, standard
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These parameters and a definition of a clinically non-
relevant difference will be used for sample size calculation
of a randomized phase III trial to show non-inferiority of
moderate aerobic endurance training versus relaxation
training in patients with migraine [24].Discussion
This is a German single-center trial to study the prophy-
lactic effect of moderate aerobic endurance training
versus relaxation training in patients with migraine. We
chose two active arms for comparison instead of inactive
‘waiting lists’ as placebo because inactive control groups
would bear a high risk of withdrawal from the trial. Fur-
thermore, relaxation training has proven to be effective
in migraine treatment [3,11-13] and facilitates compar-
ability, in contrast to medical treatment or ‘just taking a
pill’, especially when done in a similar setting to exercise
training. The study outcome depends on regular partici-
pation in either the exercise or the relaxation training
group over a period of 12 weeks. Considering that all of
the participants have not performed sports or relaxation
training on regular basis before, a relevant drop-out rate
cannot be ruled out. In the Swedish trial by Varkey et al.,
only 85% completed the training, data on about 70%
of the participants were collected at follow-up after
3 months, and only 50% of the participants returned
questionnaires after 6 months [9]. Compared to the
Swedish trial where relaxation training was performed
individually, in our trial both exercise and relaxation
training will mainly take place in a supervised group to
rule out bias due to group dynamics. The overall number
of 60 participants (30 in each study arm) may influence
the significance of the results. However, Varkey et al.
used an equal number of participants in their migraine
exercise trial. Depending on our results, a multicenter
trial with the same protocol may be planned.Trial status
Recruitment of participants started in July 2011 and is
expected to end in summer 2012.Abbreviations
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